aribio is pioneering a new paradigm of drug development known as 'ARIDD' (AI-powered, Reverse engineered & Integrated Drug Development), which promises to redefine the entire landscape of the pharmaceutical industry. Today, Ariadne continues to lead the way in transforming how drugs are developed across the industry. Ariadne's approach not only accelerates the discovery of novel drugs but also enhances the efficiency, safety, and regulatory compliance of these processes, making it an invaluable asset to the industry.

Using our ARIDD™ (AI-powered, Revers engineered & Integrated Drug Development) platform, AriBio is developing polypharmacological therapeutic agents with multiple mechanisms of action to target multiple aspects of these disease.

Private

Biotech